Drossafol, Tabletten

7680562720016 CH-56272 Tabletten

Associated product:

DROSSAFOL cpr 20 pce
Drossafol, Tabletten
Drossafol, Tabletten
Drossafol, Tabletten
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/09/2023
Patient information leaflet
Français
12/09/2023
Patient information leaflet
Italien
12/09/2023
Summary of Product Characteristics
Allemand
12/09/2023
Summary of Product Characteristics
Français
12/09/2023
Summary of Product Characteristics
Italien
12/09/2023

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
42.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Drossapharm AG

4051 Basel

Authorization information

Swissmedic authorization number
56272
Drug name
Drossafol, Tabletten
Galenic form
TAB
ATC Code
B03BB01
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
07/05/2003
Authorization expiration date
31/12/9999
IT Number
06.07.3.
Domain
Human medicine
Field of application
Durch Folsäure-Mangel verursachte megaloblastische Anämien

Package details

Description (FR)
DROSSAFOL cpr 20 pce
Description (DE)
DROSSAFOL Tabl 20 Stk
Market launch
07/05/2003
Narcotic (BTM)
No

Other package sizes (1)

DROSSAFOL cpr 100 pce
100 TABL
GTIN: 7680562720030
View